These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2165451)

  • 21. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA; Reimann S; Schrör K
    Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
    McDonald JW; Stuart RK
    J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of alpha-naphthyl thiourea-induced lung injury by prostaglandin E1 and platelet depletion.
    Fantone JC; Kunkel RG; Kinnes DA
    Lab Invest; 1984 Jun; 50(6):703-10. PubMed ID: 6233454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of prostaglandin E1 in steroidogenesis by isolated rat adrenal cells].
    Kudo M; Kudo T; Matsuki A
    Masui; 1991 Dec; 40(12):1819-24. PubMed ID: 1663172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended storage of platelets in an artificial medium with the platelet activation inhibitors prostaglandin E1 and theophylline.
    Bode AP; Holme S; Heaton WA; Swanson MS
    Vox Sang; 1991; 60(2):105-12. PubMed ID: 2031336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal function of platelet G proteins in long QT syndrome.
    Washizuka T; Aizawa Y; Fuse I; Shibata A
    Jpn Heart J; 1996 Jan; 37(1):85-93. PubMed ID: 8632628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prostaglandin E1 on platelet attenuation of oxidant-induced edema in isolated rabbit lungs.
    Heffner JE; Baron DA
    J Lab Clin Med; 1990 Dec; 116(6):797-804. PubMed ID: 2246556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
    Defreyn G; Gachet C; Savi P; Driot F; Cazenave JP; Maffrand JP
    Thromb Haemost; 1991 Feb; 65(2):186-90. PubMed ID: 2053105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets.
    Aoki Y; Inoue K; Kitahara S; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PGI2 and PGE1 induce morphological alterations in human platelets similar to those of the initial phase of activation.
    Zilla P; Groscurth P; Varga G; Fischlein T; Fasol R
    Exp Hematol; 1987 Aug; 15(7):741-9. PubMed ID: 3301381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
    J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing error in feline platelet enumeration by addition of Iloprost to blood specimens: comparison to prostaglandin E1 and EDTA.
    Tvedten HW; Bäcklund K; Lilliehöök IE
    Vet Clin Pathol; 2015 Jun; 44(2):179-87. PubMed ID: 25911961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet cyclic AMP in essential hypertension.
    Mazeaud MM; Le Quan Sang KH; Devynck MA
    J Hypertens; 1989 Jun; 7(6):501-6. PubMed ID: 2550542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micropipette aspiration of human platelets after exposure to aggregating agents.
    Burris SM; Smith CM; Tukey DT; Clawson CC; White JG
    Arteriosclerosis; 1986; 6(3):321-5. PubMed ID: 3010920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia.
    Kanof PD; Davidson M; Johns CA; Mohs RC; Davis KL
    Am J Psychiatry; 1987 Dec; 144(12):1556-60. PubMed ID: 2825548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The pharmacology of 13,14-dihydro-PGE1 in comparison with PGE1].
    Braun M; Ney P; Hohlfeld T; Szymanski C; Bruch L; Schrör K
    Vasa Suppl; 1991; 33():337-8. PubMed ID: 1788747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator.
    Addonizio VP; Strauss JF; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1979 Jan; 77(1):119-26. PubMed ID: 102876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the thiol group inhibitor monobromobimane and other inhibitors on the composition of the platelet cytoskeletal core and its association with glycoprotein IIIa.
    Puszkin EG; Mauss EA; Milot DC; Zucker MB
    J Cell Biochem; 1989 Apr; 39(4):339-54. PubMed ID: 2498343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.